Temporal changes in CT-derived fractional flow reserve in patients after heart transplantation

Simran P Sharma1,2, Javier Sanz3, Alexander Hirsch1,2

  • 1Department of Cardiology, Thorax Centre, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

European Radiology
|July 16, 2024
PubMed

Insights

Functional CT-derived fractional flow reserve (FFRct) monitoring in heart transplant (HTx) patients shows a decrease in coronary artery FFRct values and an increase in stenoses over two years. This temporal change may aid in detecting cardiac allograft vasculopathy (CAV) progression.

Area of Science:

  • Cardiology
  • Radiology
  • Transplantation Medicine

Background:

  • Cardiac allograft vasculopathy (CAV) is a significant concern in heart transplant (HTx) recipients.
  • Assessing CAV progression and its underlying pathophysiology is crucial for long-term graft survival.
  • CT-derived fractional flow reserve (FFRct) offers functional insights beyond anatomical assessment by coronary CT angiography (CCTA).

Purpose of the Study:

  • To evaluate changes in FFRct and CAV progression over a 2-year period in HTx patients.
  • To determine if temporal FFRct changes correlate with CAV development or worsening.
  • To explore the potential of FFRct as a monitoring tool in post-HTx care.

Main Methods:

  • Retrospective analysis of HTx patients with serial CCTAs performed 2 years apart.
  • Precise anatomical matching of coronary locations between baseline and follow-up scans.
  • FFRct values were measured at distal points of the LAD, LCX, and RCA, and the number of stenoses (>30%) was quantified.

Main Results:

  • A cohort of 106 HTx patients (median age 57, 67% male) was analyzed.
  • Significant decreases in distal FFRct were observed in the LAD, LCX, and RCA over 2 years (p < 0.001 to 0.009).
  • The median number of coronary stenoses (>30%) increased from 1 to 2 (p = 0.009).

Conclusions:

  • Distal coronary FFRct values decline, and the number of coronary stenoses increases in HTx patients over a 2-year follow-up.
  • Temporal changes in FFRct may serve as an additional parameter for monitoring CAV progression.
  • Further research is necessary to fully elucidate the role of temporal FFRct changes in HTx patient management.
Abstract